Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2012
10/26/2012WO2012119046A3 Heterocyclic compounds for the inhibition of pask
10/26/2012WO2012097177A3 Substituted benzoazepines as toll-like receptor modulators
10/26/2012WO2012088038A3 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
10/26/2012CA2833339A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012CA2832865A1 Aminopyrimidine kinase inhibitors
10/26/2012CA2831338A1 Androgen receptor modulating carboxamides
10/26/2012CA2830138A1 Novel pesticidal pyrazole compounds
10/26/2012CA2825971A1 5-(phenyl/pyridinyl-ethinyl) -2 -pyridine/ 2 -pyrimidine-carborxamides as mglur5 modulators
10/25/2012US20120271051 Method for producing 2-(2-aminopyrimidin-4-yl)-1h-indole-5-carboxylic acid derivatives
10/25/2012US20120271048 Novel 1,6-disubstituted indole compounds as protein kinase inhibitors
10/25/2012US20120270889 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
10/25/2012US20120270877 IRE-1alpha INHIBITORS
10/25/2012US20120270875 Pyrimidine amide compounds
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270859 Indoline derivatives and their use in treating disease-states such as cancer
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270847 Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof
10/25/2012US20120270795 Compounds for the treatment of diseases related to protein misfolding
10/25/2012US20120267620 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device
10/24/2012EP2513091A1 Hepatitis c virus inhibitors
10/24/2012EP2513090A1 Compound suitable for the treatment of synucleopathies
10/24/2012EP2513089A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/24/2012EP2513088A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513084A1 Pyrrolidine derivatives as nk - 3 receptor antagonists
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2513054A1 Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012EP2513053A1 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
10/24/2012EP2513052A1 Pyrrolidine derivatives
10/24/2012EP2512466A1 Prodrugs of inhibitors of plasma kallikrein
10/24/2012CN102753544A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753543A A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
10/24/2012CN102753542A Substituted benzoazepines as toll-like receptor modulators
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753535A Quinazolines as potassium ion channel inhibitors
10/24/2012CN102753533A Imidazolidinedione derivatives
10/24/2012CN102753524A Bicyclic derivatives useful as inhibitors of dpp-1
10/24/2012CN102753171A Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/24/2012CN102746280A Pyrimidone compound and preparation method thereof
10/24/2012CN102746279A Benzotriazole group-containing ionic liquid and its preparation method and use
10/24/2012CN102746278A Chiral pseudonucleoside compound and its preparation method and use
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN101668524B Pyrazole derivatives as 11-beta-hsd1 inhibitors
10/23/2012US8293957 Used as semiconductors in organic field-effect transistors (OFET's), organic light-emitting diodes (OLED's), sensors, and organic solar cells; good electrical properties of pentacene but are more easily obtainable and easier to purify
10/23/2012US8293923 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
10/23/2012US8293922 Processes of preparing glycolurils and cucurbiturils using microwave
10/23/2012US8293903 3-aminocyclopentanecarboxamides as chemokine receptor agonists
10/23/2012US8293902 Quinazoline compounds
10/23/2012US8293898 Luminophores
10/23/2012US8293897 Compounds comprising a spiro-ring and methods of use
10/23/2012US8293772 Triazole substituted aminobenzophenone compounds
10/23/2012US8293757 5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293748 p38 MAP kinase inhibitors
10/23/2012US8293746 Pyrimidinyl aryl urea derivatives being FGF inhibitors
10/23/2012US8293738 Indazole inhibitors of kinase
10/23/2012US8293139 Charge transport compositions and electronic devices made with such compositions
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/18/2012WO2012142367A2 Compositions and methods for treatment of pulmonary diseases and conditions
10/18/2012WO2012142029A2 Serms for the treatment of estrogen receptor-mediated disorders
10/18/2012WO2012141499A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/18/2012WO2012141228A1 Novel pyrazole derivative
10/18/2012WO2012140642A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012WO2012140001A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
10/18/2012WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10/18/2012WO2012139891A1 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
10/18/2012WO2012139775A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
10/18/2012WO2012139524A1 Cb1 receptor inhibitor with low toxicity and optical activity and preparation method and use thereof
10/18/2012WO2012115480A3 Diaminopyrimidine derivatives and processes for the preparation thereof
10/18/2012WO2012115478A3 Diaminopyrimidine derivatives and processes for the preparation thereof
10/18/2012WO2012103059A3 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
10/18/2012US20120264934 Salt forms of [R-(R*,R*)]-2-(4-flurorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
10/18/2012US20120264803 Method for predicting therapeutic effects of chemotherapy on hepatocellular carcinoma patients
10/18/2012US20120264801 5-membered heterocycle-based p38 kinase inhibitors
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264753 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
10/18/2012US20120264752 Dual-acting antihypertensive agents
10/18/2012US20120264735 Tyrosine kinase inhibitors
10/18/2012US20120264728 Amino-heteroaryl derivatives as hcn blockers
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263706 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
10/18/2012US20120263670 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
10/18/2012US20120261650 Organic electroluminescent device
10/18/2012CA2832822A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/18/2012CA2832650A1 Novel pyrazole derivative
10/17/2012EP2511263A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
10/17/2012EP2509977A1 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof
10/17/2012EP2509975A1 Benzimidazole inhibitors of leukotriene production
10/17/2012EP2509974A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
10/17/2012EP2509961A1 Imidazolidinedione derivatives
10/17/2012EP2509960A1 Tgr5 agonists
10/17/2012EP2509955A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel
10/17/2012EP2509946A1 Spiro indole - cyclopropane indolinones useful as ampk modulators
10/17/2012CN102741242A Hepatitis c virus inhibitors
10/17/2012CN102741241A Benzimidazole-imidazole derivatives
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 626